CURE^® TV

With CURE TV^®, you have access to a variety of informative and uplifting videos. You’ll find interviews with cancer experts, advocates, patients, caregivers, as well as highlights from our celebratory events showcasing interviews with award winners and celebrity speakers.

The Importance of Genetic Testing in Metastatic Colorectal Cancer

February 21st 2025, 10:00pm

Video

An expert explains the importance of genetic testing in metastatic colorectal cancer, as recent FDA approval highlights its role in guiding targeted treatments.

How Patients With Cancer Can Avoid Counterfeit Therapeutics Online

February 21st 2025, 5:00pm

Article

Dr. Megan Menon explains how patients can verify the authenticity of online prescription purchases for their cancer treatment.

Personalized Cancer Vaccine Demonstrates Responses in Kidney Cancer

February 20th 2025, 5:00pm

Video

Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a vaccine.

Krazati and Erbitux Combo Benefits KRAS G12C+ Metastatic Colorectal Cancer

February 20th 2025, 4:00pm

Video

Dr. Nataliya Uboha explained the benefit of treatment with Krazati combined with Erbitux in KRAS G12C–mutant metastatic colorectal cancer.

Explaining PROs From the TiNivo-2 Study in Advanced Renal Cell Carcinoma

February 19th 2025, 5:00pm

Video

Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.

An Expert Breaks Down the Effect of Diabetes on Urothelial Cancer Treatment

February 18th 2025, 5:00pm

Video

Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.

Understanding the Distinction Between HER2-Low and HER2-Ultralow Breast Cancer

February 17th 2025, 10:00pm

Video

Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.

An Expert Explains The Risk and Outcomes of Primary Urothelial Cancer Treatment

February 17th 2025, 5:00pm

Video

Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.